Summary
Human volunteers inoculated with mouse-adapted type II dengue virus (New Guinea B strain) responded with mild clinical reactions indicating that the virus had become attenuated in a manner comparable to that previously shown for type I virus (Hawaii strain). The most significant and consistent sign was a maculopapular rash.
In 10 of 11 volunteers, a single dose of attenuated type II dengue virus induced formation of homologous neutralizing antibody.
When attenuated type II virus was given in combination with yellow fever vaccine or with yellow fever vaccine and attenuated type I dengue virus, the resulting antibody response was predominantly to type II virus, indicating suppression of the other antigens presumably as a result of interference. Not enough volunteers were available to vary the relative concentration of the components in the mixtures.
Attenuated type II dengue virus or combined vaccine was inadvertently administered to 4 men who had been immunized against yellow fever 7–7 ½ years previously. These men gave an anamnestic immune response characterized by rapid production of complement-fixing (3 men only) and neutralizing antibodies of comparable potency against types I and II dengue and yellow fever viruses.
The findings suggest consecutive immunization with yellow fever and an attenuated, related viral antigen as a possible method of broad-spectrum prophylaxis.
Footnotes
-
↵2 Present address: Department of Microbiology, Saint Louis University School of Medicine, Saint Louis 4, Missouri.
-
↵1 This investigation was supported in part by research grant No. E-113 from the National Institutes of Health, U. S. Public Health Service. Parts of the studies were done under the sponsorship of the Commission on Liver Disease, Armed Forces Epidemiological Board, and were supported by the Office of the Surgeon General, Department of the Army.
- Received July 3, 1956.
- Copyright © 1956 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Log in using your username and password
In this issue
